Article Menu

Export Article

More by Authors Links

Article Data

  • Views 61
  • Dowloads 18

Retractions

Open Access

Retraction: Syringaresinol mitigates cerebral ischemia-induced brain injury via NF-κB pathway inhibition and glial cell deactivation

  • Chengfeng Wang1
  • Xiaoyan He1
  • Reyisha Taximaimaiti1
  • Chunli Zhang1
  • Hongyan Li1,*,

1Department of Neurology, People’s Hospital of Xinjiang Uygur Autonomous Region, 830001 Urumqi, Xinjiang Uygur Autonomous Region, China

DOI: 10.22514/sv.2026.074 Vol.22,Issue 3,August 2026 pp.204-204

Published: 08 August 2026

*Corresponding Author(s): Hongyan Li E-mail: Lihongyan_666@163.com

PDF (102.63 kB) View Full-text

Cite and Share

Wang C, He X, Taximaimaiti R, Zhang C, Li H. Retraction: Syringaresinol mitigates cerebral ischemia-induced brain injury via NF-κB pathway inhibition and glial cell deactivation. Signa Vitae. 2026; 22(3): 204-204. doi: 10.22514/sv.2026.074

URL:

https://www.signavitae.com/articles/10.22514/sv.2026.074

References

[1] Wang CF, He XY, Taximaimaiti R, Zhang CL, Li HY. Syringaresinol mitigates cerebral ischemia-induced brain injury via NF-κB pathway inhibition and glial cell deactivation. Signa Vitae. 2025; 21: 111–117.

Submission Turnaround Time

Top